A study recently published in Dermatologic Surgery (2011, 37, 858-861) by Dr Leonard Goldberg and colleagues from the Department of Dermatology, Weill Cornell Medical College in Houston, Texas has shown that treatment with the cream Curaderm BEC5 eliminated squamous cell carcinoma (Bown’s Disease) on the penis. A previous attempt to treat this cancer with two courses of Imiquimod (Aldara) failed as the lesion returned 1 year after treatment with the second course of Aldara.
During treatment with Curaderm BEC5 the patient experienced the typical response to Curaderm BEC5, including inflammation and necrosis followed by ulceration and recpithelialization (regrowth of normal skin) of the treated skin. There was complete clinical regression of the patient’s tumour. The treatmet of this tumour with Curaderm BEC5 resulted in the sparing of tissue and preserved the functionality and thus Curaderm BEC5 treatment was superior to other more-destructive treatment options for Bown’s disease of the penis.
It was similarly shown in another recent independent publication in the Journal of Cancer Therapy (2011, 2, 728-745) by T. R. Chase at the Australasian Medical Research Centre that Curaderm BEC5 treated other large skin tumours including a large squamous cell carcinoma on the penis. The article was appropriately titled: Curaderm BEC5 for Skin Cancers, is it? An Overview.
The conclusion of the published article was: Curaderm BEC5 for Skin Cancers, it is!
